nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PPARG—Alzheimer's disease	0.238	0.463	CbGaD
Indomethacin—PTGS1—Alzheimer's disease	0.176	0.342	CbGaD
Indomethacin—PTGS2—Alzheimer's disease	0.101	0.195	CbGaD
Indomethacin—CYP2C19—Memantine—Alzheimer's disease	0.0234	0.51	CbGbCtD
Indomethacin—CYP2C9—Donepezil—Alzheimer's disease	0.0224	0.489	CbGbCtD
Indomethacin—SLC22A8—choroid plexus—Alzheimer's disease	0.00984	0.136	CbGeAlD
Indomethacin—PTGR2—embryo—Alzheimer's disease	0.0032	0.0442	CbGeAlD
Indomethacin—ABCC11—embryo—Alzheimer's disease	0.00317	0.0438	CbGeAlD
Indomethacin—PPARA—blood vessel—Alzheimer's disease	0.00288	0.0398	CbGeAlD
Indomethacin—PTGDR2—cerebellum—Alzheimer's disease	0.00218	0.0301	CbGeAlD
Indomethacin—PTGDR2—brain—Alzheimer's disease	0.00177	0.0244	CbGeAlD
Indomethacin—GLO1—forebrain—Alzheimer's disease	0.00175	0.0242	CbGeAlD
Indomethacin—PPARA—embryo—Alzheimer's disease	0.00172	0.0237	CbGeAlD
Indomethacin—GLO1—telencephalon—Alzheimer's disease	0.00161	0.0222	CbGeAlD
Indomethacin—PPARG—blood vessel—Alzheimer's disease	0.00158	0.0219	CbGeAlD
Indomethacin—PTGR2—nervous system—Alzheimer's disease	0.00154	0.0212	CbGeAlD
Indomethacin—PLA2G2A—telencephalon—Alzheimer's disease	0.0015	0.0206	CbGeAlD
Indomethacin—PTGR2—central nervous system—Alzheimer's disease	0.00148	0.0204	CbGeAlD
Indomethacin—PTGR2—cerebellum—Alzheimer's disease	0.00145	0.02	CbGeAlD
Indomethacin—PTGR2—brain—Alzheimer's disease	0.00117	0.0162	CbGeAlD
Indomethacin—GLO1—nervous system—Alzheimer's disease	0.00095	0.0131	CbGeAlD
Indomethacin—PPARG—embryo—Alzheimer's disease	0.000944	0.013	CbGeAlD
Indomethacin—GLO1—central nervous system—Alzheimer's disease	0.000914	0.0126	CbGeAlD
Indomethacin—Tolmetin—MPO—Alzheimer's disease	0.000897	0.197	CrCbGaD
Indomethacin—GLO1—cerebellum—Alzheimer's disease	0.000894	0.0123	CbGeAlD
Indomethacin—PLA2G2A—nervous system—Alzheimer's disease	0.000883	0.0122	CbGeAlD
Indomethacin—Bromfenac—PTGS1—Alzheimer's disease	0.000875	0.192	CrCbGaD
Indomethacin—PLA2G2A—central nervous system—Alzheimer's disease	0.00085	0.0117	CbGeAlD
Indomethacin—PTGS1—blood vessel—Alzheimer's disease	0.000846	0.0117	CbGeAlD
Indomethacin—PPARG—forebrain—Alzheimer's disease	0.000835	0.0115	CbGeAlD
Indomethacin—PPARA—nervous system—Alzheimer's disease	0.000825	0.0114	CbGeAlD
Indomethacin—CXCL8—cerebellum—Alzheimer's disease	0.000822	0.0114	CbGeAlD
Indomethacin—PTGS2—blood vessel—Alzheimer's disease	0.000809	0.0112	CbGeAlD
Indomethacin—PPARA—central nervous system—Alzheimer's disease	0.000794	0.011	CbGeAlD
Indomethacin—SLC10A1—nervous system—Alzheimer's disease	0.000793	0.0109	CbGeAlD
Indomethacin—SLCO1A2—forebrain—Alzheimer's disease	0.000788	0.0109	CbGeAlD
Indomethacin—PPARA—cerebellum—Alzheimer's disease	0.000776	0.0107	CbGeAlD
Indomethacin—SLC10A1—central nervous system—Alzheimer's disease	0.000763	0.0105	CbGeAlD
Indomethacin—ABCC4—forebrain—Alzheimer's disease	0.000759	0.0105	CbGeAlD
Indomethacin—GLO1—brain—Alzheimer's disease	0.000726	0.01	CbGeAlD
Indomethacin—SLCO1A2—telencephalon—Alzheimer's disease	0.000725	0.01	CbGeAlD
Indomethacin—PLA2G2A—brain—Alzheimer's disease	0.000675	0.00932	CbGeAlD
Indomethacin—CXCL8—brain—Alzheimer's disease	0.000668	0.00922	CbGeAlD
Indomethacin—Bezafibrate—PPARG—Alzheimer's disease	0.000655	0.144	CrCbGaD
Indomethacin—AKR1C3—cerebellum—Alzheimer's disease	0.000645	0.0089	CbGeAlD
Indomethacin—PPARA—brain—Alzheimer's disease	0.00063	0.0087	CbGeAlD
Indomethacin—CES1—nervous system—Alzheimer's disease	0.000612	0.00845	CbGeAlD
Indomethacin—SLC10A1—brain—Alzheimer's disease	0.000606	0.00837	CbGeAlD
Indomethacin—ABCC1—telencephalon—Alzheimer's disease	0.000595	0.00821	CbGeAlD
Indomethacin—CES1—central nervous system—Alzheimer's disease	0.000589	0.00813	CbGeAlD
Indomethacin—Tolmetin—PTGS1—Alzheimer's disease	0.000588	0.129	CrCbGaD
Indomethacin—SLC22A7—brain—Alzheimer's disease	0.00054	0.00746	CbGeAlD
Indomethacin—AKR1C3—brain—Alzheimer's disease	0.000524	0.00723	CbGeAlD
Indomethacin—SLC22A6—brain—Alzheimer's disease	0.000522	0.0072	CbGeAlD
Indomethacin—ABCB1—blood vessel—Alzheimer's disease	0.0005	0.00691	CbGeAlD
Indomethacin—Bromfenac—PTGS2—Alzheimer's disease	0.0005	0.11	CrCbGaD
Indomethacin—ABCC3—nervous system—Alzheimer's disease	0.000499	0.00689	CbGeAlD
Indomethacin—Gastritis—Memantine—Alzheimer's disease	0.000493	0.00239	CcSEcCtD
Indomethacin—Muscular weakness—Memantine—Alzheimer's disease	0.000491	0.00239	CcSEcCtD
Indomethacin—Pollakiuria—Donepezil—Alzheimer's disease	0.00049	0.00238	CcSEcCtD
Indomethacin—Arrhythmia—Galantamine—Alzheimer's disease	0.000489	0.00238	CcSEcCtD
Indomethacin—Weight increased—Donepezil—Alzheimer's disease	0.000483	0.00234	CcSEcCtD
Indomethacin—PTGS2—embryo—Alzheimer's disease	0.000483	0.00666	CbGeAlD
Indomethacin—Gastritis—Rivastigmine—Alzheimer's disease	0.000482	0.00234	CcSEcCtD
Indomethacin—Asthma—Memantine—Alzheimer's disease	0.000482	0.00234	CcSEcCtD
Indomethacin—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000481	0.00233	CcSEcCtD
Indomethacin—ABCC3—central nervous system—Alzheimer's disease	0.00048	0.00663	CbGeAlD
Indomethacin—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000478	0.00232	CcSEcCtD
Indomethacin—Depression—Donepezil—Alzheimer's disease	0.000472	0.00229	CcSEcCtD
Indomethacin—Flatulence—Galantamine—Alzheimer's disease	0.00047	0.00228	CcSEcCtD
Indomethacin—Tension—Galantamine—Alzheimer's disease	0.000468	0.00227	CcSEcCtD
Indomethacin—CES1—brain—Alzheimer's disease	0.000468	0.00646	CbGeAlD
Indomethacin—Renal failure—Donepezil—Alzheimer's disease	0.000465	0.00226	CcSEcCtD
Indomethacin—Nervousness—Galantamine—Alzheimer's disease	0.000463	0.00225	CcSEcCtD
Indomethacin—Jaundice—Donepezil—Alzheimer's disease	0.000461	0.00224	CcSEcCtD
Indomethacin—Pancytopenia—Memantine—Alzheimer's disease	0.000457	0.00222	CcSEcCtD
Indomethacin—PPARG—nervous system—Alzheimer's disease	0.000453	0.00626	CbGeAlD
Indomethacin—Sweating—Donepezil—Alzheimer's disease	0.000453	0.0022	CcSEcCtD
Indomethacin—Haematuria—Donepezil—Alzheimer's disease	0.000451	0.00219	CcSEcCtD
Indomethacin—Vision blurred—Galantamine—Alzheimer's disease	0.000449	0.00218	CcSEcCtD
Indomethacin—PTGS1—forebrain—Alzheimer's disease	0.000447	0.00617	CbGeAlD
Indomethacin—Epistaxis—Donepezil—Alzheimer's disease	0.000446	0.00217	CcSEcCtD
Indomethacin—Pollakiuria—Memantine—Alzheimer's disease	0.000445	0.00216	CcSEcCtD
Indomethacin—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000442	0.00215	CcSEcCtD
Indomethacin—Naproxen—PTGS1—Alzheimer's disease	0.000442	0.0973	CrCbGaD
Indomethacin—Anaemia—Galantamine—Alzheimer's disease	0.000441	0.00214	CcSEcCtD
Indomethacin—Weight increased—Memantine—Alzheimer's disease	0.000438	0.00213	CcSEcCtD
Indomethacin—PPARG—central nervous system—Alzheimer's disease	0.000437	0.00603	CbGeAlD
Indomethacin—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000435	0.00211	CcSEcCtD
Indomethacin—Hyperglycaemia—Memantine—Alzheimer's disease	0.000434	0.00211	CcSEcCtD
Indomethacin—Bradycardia—Donepezil—Alzheimer's disease	0.000432	0.0021	CcSEcCtD
Indomethacin—Malaise—Galantamine—Alzheimer's disease	0.00043	0.00209	CcSEcCtD
Indomethacin—Weight increased—Rivastigmine—Alzheimer's disease	0.000429	0.00208	CcSEcCtD
Indomethacin—Vertigo—Galantamine—Alzheimer's disease	0.000428	0.00208	CcSEcCtD
Indomethacin—Depression—Memantine—Alzheimer's disease	0.000428	0.00208	CcSEcCtD
Indomethacin—SLCO1A2—nervous system—Alzheimer's disease	0.000428	0.00591	CbGeAlD
Indomethacin—Syncope—Galantamine—Alzheimer's disease	0.000428	0.00208	CcSEcCtD
Indomethacin—PTGS2—forebrain—Alzheimer's disease	0.000427	0.00589	CbGeAlD
Indomethacin—Haemoglobin—Donepezil—Alzheimer's disease	0.000427	0.00207	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000426	0.00207	CcSEcCtD
Indomethacin—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000425	0.00206	CcSEcCtD
Indomethacin—Haemorrhage—Donepezil—Alzheimer's disease	0.000425	0.00206	CcSEcCtD
Indomethacin—Hepatitis—Donepezil—Alzheimer's disease	0.000425	0.00206	CcSEcCtD
Indomethacin—Renal failure—Memantine—Alzheimer's disease	0.000422	0.00205	CcSEcCtD
Indomethacin—Palpitations—Galantamine—Alzheimer's disease	0.000421	0.00205	CcSEcCtD
Indomethacin—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000421	0.00204	CcSEcCtD
Indomethacin—Drowsiness—Rivastigmine—Alzheimer's disease	0.00042	0.00204	CcSEcCtD
Indomethacin—Loss of consciousness—Galantamine—Alzheimer's disease	0.000419	0.00203	CcSEcCtD
Indomethacin—Depression—Rivastigmine—Alzheimer's disease	0.000419	0.00203	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000416	0.00202	CcSEcCtD
Indomethacin—Convulsion—Galantamine—Alzheimer's disease	0.000413	0.00201	CcSEcCtD
Indomethacin—Renal failure—Rivastigmine—Alzheimer's disease	0.000413	0.002	CcSEcCtD
Indomethacin—SLCO1A2—central nervous system—Alzheimer's disease	0.000412	0.00569	CbGeAlD
Indomethacin—ABCC4—nervous system—Alzheimer's disease	0.000412	0.00569	CbGeAlD
Indomethacin—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000412	0.002	CcSEcCtD
Indomethacin—Hypertension—Galantamine—Alzheimer's disease	0.000412	0.002	CcSEcCtD
Indomethacin—PTGS1—telencephalon—Alzheimer's disease	0.000411	0.00567	CbGeAlD
Indomethacin—Haematuria—Memantine—Alzheimer's disease	0.000409	0.00199	CcSEcCtD
Indomethacin—SLC22A8—nervous system—Alzheimer's disease	0.000409	0.00564	CbGeAlD
Indomethacin—Chest pain—Galantamine—Alzheimer's disease	0.000406	0.00197	CcSEcCtD
Indomethacin—Epistaxis—Memantine—Alzheimer's disease	0.000405	0.00197	CcSEcCtD
Indomethacin—Anxiety—Galantamine—Alzheimer's disease	0.000405	0.00196	CcSEcCtD
Indomethacin—Sweating—Rivastigmine—Alzheimer's disease	0.000403	0.00196	CcSEcCtD
Indomethacin—SLCO1A2—cerebellum—Alzheimer's disease	0.000403	0.00556	CbGeAlD
Indomethacin—Discomfort—Galantamine—Alzheimer's disease	0.000401	0.00195	CcSEcCtD
Indomethacin—Agranulocytosis—Memantine—Alzheimer's disease	0.000401	0.00195	CcSEcCtD
Indomethacin—Haematuria—Rivastigmine—Alzheimer's disease	0.000401	0.00194	CcSEcCtD
Indomethacin—ABCC4—central nervous system—Alzheimer's disease	0.000396	0.00547	CbGeAlD
Indomethacin—Epistaxis—Rivastigmine—Alzheimer's disease	0.000396	0.00192	CcSEcCtD
Indomethacin—Tinnitus—Donepezil—Alzheimer's disease	0.000396	0.00192	CcSEcCtD
Indomethacin—SLC22A8—central nervous system—Alzheimer's disease	0.000393	0.00543	CbGeAlD
Indomethacin—PTGS2—telencephalon—Alzheimer's disease	0.000392	0.00542	CbGeAlD
Indomethacin—Confusional state—Galantamine—Alzheimer's disease	0.000392	0.00191	CcSEcCtD
Indomethacin—Bradycardia—Memantine—Alzheimer's disease	0.000392	0.00191	CcSEcCtD
Indomethacin—Haemoglobin—Memantine—Alzheimer's disease	0.000387	0.00188	CcSEcCtD
Indomethacin—Hepatitis—Memantine—Alzheimer's disease	0.000385	0.00187	CcSEcCtD
Indomethacin—Haemorrhage—Memantine—Alzheimer's disease	0.000385	0.00187	CcSEcCtD
Indomethacin—Bradycardia—Rivastigmine—Alzheimer's disease	0.000384	0.00186	CcSEcCtD
Indomethacin—Shock—Galantamine—Alzheimer's disease	0.000383	0.00186	CcSEcCtD
Indomethacin—ABCC3—brain—Alzheimer's disease	0.000381	0.00526	CbGeAlD
Indomethacin—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000381	0.00185	CcSEcCtD
Indomethacin—Tachycardia—Galantamine—Alzheimer's disease	0.00038	0.00184	CcSEcCtD
Indomethacin—Arrhythmia—Donepezil—Alzheimer's disease	0.000379	0.00184	CcSEcCtD
Indomethacin—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000379	0.00184	CcSEcCtD
Indomethacin—Hepatitis—Rivastigmine—Alzheimer's disease	0.000377	0.00183	CcSEcCtD
Indomethacin—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000377	0.00183	CcSEcCtD
Indomethacin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000376	0.00183	CcSEcCtD
Indomethacin—Alopecia—Donepezil—Alzheimer's disease	0.000375	0.00182	CcSEcCtD
Indomethacin—Anorexia—Galantamine—Alzheimer's disease	0.000371	0.0018	CcSEcCtD
Indomethacin—Erythema—Donepezil—Alzheimer's disease	0.00037	0.00179	CcSEcCtD
Indomethacin—Erythema multiforme—Memantine—Alzheimer's disease	0.000364	0.00177	CcSEcCtD
Indomethacin—Flatulence—Donepezil—Alzheimer's disease	0.000364	0.00177	CcSEcCtD
Indomethacin—Hypotension—Galantamine—Alzheimer's disease	0.000364	0.00177	CcSEcCtD
Indomethacin—Tension—Donepezil—Alzheimer's disease	0.000363	0.00176	CcSEcCtD
Indomethacin—Tinnitus—Memantine—Alzheimer's disease	0.000359	0.00174	CcSEcCtD
Indomethacin—Nervousness—Donepezil—Alzheimer's disease	0.000359	0.00174	CcSEcCtD
Indomethacin—Flushing—Memantine—Alzheimer's disease	0.000358	0.00174	CcSEcCtD
Indomethacin—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000357	0.00173	CcSEcCtD
Indomethacin—Insomnia—Galantamine—Alzheimer's disease	0.000352	0.00171	CcSEcCtD
Indomethacin—Tinnitus—Rivastigmine—Alzheimer's disease	0.000352	0.00171	CcSEcCtD
Indomethacin—Flushing—Rivastigmine—Alzheimer's disease	0.00035	0.0017	CcSEcCtD
Indomethacin—Paraesthesia—Galantamine—Alzheimer's disease	0.000349	0.0017	CcSEcCtD
Indomethacin—Vision blurred—Donepezil—Alzheimer's disease	0.000348	0.00169	CcSEcCtD
Indomethacin—PPARG—brain—Alzheimer's disease	0.000347	0.00479	CbGeAlD
Indomethacin—Somnolence—Galantamine—Alzheimer's disease	0.000346	0.00168	CcSEcCtD
Indomethacin—Arrhythmia—Memantine—Alzheimer's disease	0.000344	0.00167	CcSEcCtD
Indomethacin—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000343	0.00166	CcSEcCtD
Indomethacin—Dyspepsia—Galantamine—Alzheimer's disease	0.000343	0.00166	CcSEcCtD
Indomethacin—Anaemia—Donepezil—Alzheimer's disease	0.000342	0.00166	CcSEcCtD
Indomethacin—Alopecia—Memantine—Alzheimer's disease	0.000341	0.00165	CcSEcCtD
Indomethacin—Decreased appetite—Galantamine—Alzheimer's disease	0.000338	0.00164	CcSEcCtD
Indomethacin—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000337	0.00164	CcSEcCtD
Indomethacin—Tolmetin—PTGS2—Alzheimer's disease	0.000336	0.0739	CrCbGaD
Indomethacin—Fatigue—Galantamine—Alzheimer's disease	0.000336	0.00163	CcSEcCtD
Indomethacin—Malaise—Donepezil—Alzheimer's disease	0.000333	0.00162	CcSEcCtD
Indomethacin—Alopecia—Rivastigmine—Alzheimer's disease	0.000333	0.00162	CcSEcCtD
Indomethacin—Constipation—Galantamine—Alzheimer's disease	0.000333	0.00162	CcSEcCtD
Indomethacin—Vertigo—Donepezil—Alzheimer's disease	0.000332	0.00161	CcSEcCtD
Indomethacin—Syncope—Donepezil—Alzheimer's disease	0.000331	0.00161	CcSEcCtD
Indomethacin—Flatulence—Memantine—Alzheimer's disease	0.000331	0.00161	CcSEcCtD
Indomethacin—ABCC1—cerebellum—Alzheimer's disease	0.00033	0.00456	CbGeAlD
Indomethacin—Tension—Memantine—Alzheimer's disease	0.000329	0.0016	CcSEcCtD
Indomethacin—Erythema—Rivastigmine—Alzheimer's disease	0.000328	0.00159	CcSEcCtD
Indomethacin—SLCO1A2—brain—Alzheimer's disease	0.000327	0.00452	CbGeAlD
Indomethacin—Nervousness—Memantine—Alzheimer's disease	0.000326	0.00158	CcSEcCtD
Indomethacin—ALB—brain—Alzheimer's disease	0.000325	0.00449	CbGeAlD
Indomethacin—Loss of consciousness—Donepezil—Alzheimer's disease	0.000325	0.00158	CcSEcCtD
Indomethacin—Flatulence—Rivastigmine—Alzheimer's disease	0.000323	0.00157	CcSEcCtD
Indomethacin—Tension—Rivastigmine—Alzheimer's disease	0.000322	0.00156	CcSEcCtD
Indomethacin—Feeling abnormal—Galantamine—Alzheimer's disease	0.000321	0.00156	CcSEcCtD
Indomethacin—Convulsion—Donepezil—Alzheimer's disease	0.00032	0.00155	CcSEcCtD
Indomethacin—Hypertension—Donepezil—Alzheimer's disease	0.000319	0.00155	CcSEcCtD
Indomethacin—Nervousness—Rivastigmine—Alzheimer's disease	0.000319	0.00155	CcSEcCtD
Indomethacin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000318	0.00155	CcSEcCtD
Indomethacin—Vision blurred—Memantine—Alzheimer's disease	0.000316	0.00154	CcSEcCtD
Indomethacin—ABCC4—brain—Alzheimer's disease	0.000315	0.00435	CbGeAlD
Indomethacin—Chest pain—Donepezil—Alzheimer's disease	0.000315	0.00153	CcSEcCtD
Indomethacin—Anxiety—Donepezil—Alzheimer's disease	0.000314	0.00152	CcSEcCtD
Indomethacin—SLC22A8—brain—Alzheimer's disease	0.000312	0.00431	CbGeAlD
Indomethacin—Ill-defined disorder—Memantine—Alzheimer's disease	0.000311	0.00151	CcSEcCtD
Indomethacin—Discomfort—Donepezil—Alzheimer's disease	0.000311	0.00151	CcSEcCtD
Indomethacin—Anaemia—Memantine—Alzheimer's disease	0.00031	0.00151	CcSEcCtD
Indomethacin—Vision blurred—Rivastigmine—Alzheimer's disease	0.000309	0.0015	CcSEcCtD
Indomethacin—Abdominal pain—Galantamine—Alzheimer's disease	0.000308	0.00149	CcSEcCtD
Indomethacin—Body temperature increased—Galantamine—Alzheimer's disease	0.000308	0.00149	CcSEcCtD
Indomethacin—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000305	0.00148	CcSEcCtD
Indomethacin—Confusional state—Donepezil—Alzheimer's disease	0.000304	0.00148	CcSEcCtD
Indomethacin—Anaemia—Rivastigmine—Alzheimer's disease	0.000303	0.00147	CcSEcCtD
Indomethacin—Malaise—Memantine—Alzheimer's disease	0.000303	0.00147	CcSEcCtD
Indomethacin—Oedema—Donepezil—Alzheimer's disease	0.000302	0.00146	CcSEcCtD
Indomethacin—Vertigo—Memantine—Alzheimer's disease	0.000301	0.00146	CcSEcCtD
Indomethacin—Syncope—Memantine—Alzheimer's disease	0.000301	0.00146	CcSEcCtD
Indomethacin—Leukopenia—Memantine—Alzheimer's disease	0.0003	0.00146	CcSEcCtD
Indomethacin—ABCB1—embryo—Alzheimer's disease	0.000299	0.00412	CbGeAlD
Indomethacin—Shock—Donepezil—Alzheimer's disease	0.000297	0.00144	CcSEcCtD
Indomethacin—Palpitations—Memantine—Alzheimer's disease	0.000297	0.00144	CcSEcCtD
Indomethacin—Malaise—Rivastigmine—Alzheimer's disease	0.000296	0.00144	CcSEcCtD
Indomethacin—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000295	0.00143	CcSEcCtD
Indomethacin—Vertigo—Rivastigmine—Alzheimer's disease	0.000295	0.00143	CcSEcCtD
Indomethacin—Loss of consciousness—Memantine—Alzheimer's disease	0.000295	0.00143	CcSEcCtD
Indomethacin—Syncope—Rivastigmine—Alzheimer's disease	0.000294	0.00143	CcSEcCtD
Indomethacin—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000292	0.00142	CcSEcCtD
Indomethacin—Convulsion—Memantine—Alzheimer's disease	0.000291	0.00141	CcSEcCtD
Indomethacin—Palpitations—Rivastigmine—Alzheimer's disease	0.00029	0.00141	CcSEcCtD
Indomethacin—Hypertension—Memantine—Alzheimer's disease	0.00029	0.00141	CcSEcCtD
Indomethacin—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000289	0.0014	CcSEcCtD
Indomethacin—Anorexia—Donepezil—Alzheimer's disease	0.000287	0.0014	CcSEcCtD
Indomethacin—Hypersensitivity—Galantamine—Alzheimer's disease	0.000287	0.00139	CcSEcCtD
Indomethacin—Chest pain—Memantine—Alzheimer's disease	0.000286	0.00139	CcSEcCtD
Indomethacin—Anxiety—Memantine—Alzheimer's disease	0.000285	0.00138	CcSEcCtD
Indomethacin—Convulsion—Rivastigmine—Alzheimer's disease	0.000284	0.00138	CcSEcCtD
Indomethacin—Hypertension—Rivastigmine—Alzheimer's disease	0.000283	0.00138	CcSEcCtD
Indomethacin—Discomfort—Memantine—Alzheimer's disease	0.000282	0.00137	CcSEcCtD
Indomethacin—Hypotension—Donepezil—Alzheimer's disease	0.000282	0.00137	CcSEcCtD
Indomethacin—Chest pain—Rivastigmine—Alzheimer's disease	0.000279	0.00136	CcSEcCtD
Indomethacin—Asthenia—Galantamine—Alzheimer's disease	0.000279	0.00136	CcSEcCtD
Indomethacin—Anxiety—Rivastigmine—Alzheimer's disease	0.000278	0.00135	CcSEcCtD
Indomethacin—Confusional state—Memantine—Alzheimer's disease	0.000276	0.00134	CcSEcCtD
Indomethacin—Discomfort—Rivastigmine—Alzheimer's disease	0.000276	0.00134	CcSEcCtD
Indomethacin—Oedema—Memantine—Alzheimer's disease	0.000274	0.00133	CcSEcCtD
Indomethacin—Insomnia—Donepezil—Alzheimer's disease	0.000273	0.00132	CcSEcCtD
Indomethacin—Paraesthesia—Donepezil—Alzheimer's disease	0.000271	0.00131	CcSEcCtD
Indomethacin—Confusional state—Rivastigmine—Alzheimer's disease	0.00027	0.00131	CcSEcCtD
Indomethacin—Shock—Memantine—Alzheimer's disease	0.000269	0.00131	CcSEcCtD
Indomethacin—Dyspnoea—Donepezil—Alzheimer's disease	0.000269	0.00131	CcSEcCtD
Indomethacin—ABCC1—brain—Alzheimer's disease	0.000268	0.00371	CbGeAlD
Indomethacin—Somnolence—Donepezil—Alzheimer's disease	0.000268	0.0013	CcSEcCtD
Indomethacin—Thrombocytopenia—Memantine—Alzheimer's disease	0.000268	0.0013	CcSEcCtD
Indomethacin—Oedema—Rivastigmine—Alzheimer's disease	0.000268	0.0013	CcSEcCtD
Indomethacin—Tachycardia—Memantine—Alzheimer's disease	0.000267	0.0013	CcSEcCtD
Indomethacin—Diarrhoea—Galantamine—Alzheimer's disease	0.000266	0.00129	CcSEcCtD
Indomethacin—Dyspepsia—Donepezil—Alzheimer's disease	0.000265	0.00129	CcSEcCtD
Indomethacin—Hyperhidrosis—Memantine—Alzheimer's disease	0.000265	0.00129	CcSEcCtD
Indomethacin—ABCB1—forebrain—Alzheimer's disease	0.000264	0.00365	CbGeAlD
Indomethacin—Shock—Rivastigmine—Alzheimer's disease	0.000264	0.00128	CcSEcCtD
Indomethacin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000262	0.00127	CcSEcCtD
Indomethacin—Decreased appetite—Donepezil—Alzheimer's disease	0.000262	0.00127	CcSEcCtD
Indomethacin—Tachycardia—Rivastigmine—Alzheimer's disease	0.000261	0.00127	CcSEcCtD
Indomethacin—Anorexia—Memantine—Alzheimer's disease	0.000261	0.00127	CcSEcCtD
Indomethacin—Fatigue—Donepezil—Alzheimer's disease	0.00026	0.00126	CcSEcCtD
Indomethacin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000259	0.00126	CcSEcCtD
Indomethacin—Pain—Donepezil—Alzheimer's disease	0.000258	0.00125	CcSEcCtD
Indomethacin—Constipation—Donepezil—Alzheimer's disease	0.000258	0.00125	CcSEcCtD
Indomethacin—Dizziness—Galantamine—Alzheimer's disease	0.000257	0.00125	CcSEcCtD
Indomethacin—Hypotension—Memantine—Alzheimer's disease	0.000256	0.00124	CcSEcCtD
Indomethacin—Anorexia—Rivastigmine—Alzheimer's disease	0.000255	0.00124	CcSEcCtD
Indomethacin—Naproxen—PTGS2—Alzheimer's disease	0.000253	0.0556	CrCbGaD
Indomethacin—Hypotension—Rivastigmine—Alzheimer's disease	0.00025	0.00122	CcSEcCtD
Indomethacin—Feeling abnormal—Donepezil—Alzheimer's disease	0.000249	0.00121	CcSEcCtD
Indomethacin—Insomnia—Memantine—Alzheimer's disease	0.000248	0.0012	CcSEcCtD
Indomethacin—Vomiting—Galantamine—Alzheimer's disease	0.000247	0.0012	CcSEcCtD
Indomethacin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000247	0.0012	CcSEcCtD
Indomethacin—Paraesthesia—Memantine—Alzheimer's disease	0.000246	0.00119	CcSEcCtD
Indomethacin—Rash—Galantamine—Alzheimer's disease	0.000245	0.00119	CcSEcCtD
Indomethacin—Dermatitis—Galantamine—Alzheimer's disease	0.000245	0.00119	CcSEcCtD
Indomethacin—Dyspnoea—Memantine—Alzheimer's disease	0.000244	0.00119	CcSEcCtD
Indomethacin—Headache—Galantamine—Alzheimer's disease	0.000244	0.00118	CcSEcCtD
Indomethacin—Somnolence—Memantine—Alzheimer's disease	0.000243	0.00118	CcSEcCtD
Indomethacin—ABCB1—telencephalon—Alzheimer's disease	0.000243	0.00335	CbGeAlD
Indomethacin—PTGS1—nervous system—Alzheimer's disease	0.000242	0.00335	CbGeAlD
Indomethacin—Insomnia—Rivastigmine—Alzheimer's disease	0.000242	0.00118	CcSEcCtD
Indomethacin—Dyspepsia—Memantine—Alzheimer's disease	0.000241	0.00117	CcSEcCtD
Indomethacin—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000241	0.00117	CcSEcCtD
Indomethacin—Urticaria—Donepezil—Alzheimer's disease	0.00024	0.00116	CcSEcCtD
Indomethacin—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000239	0.00116	CcSEcCtD
Indomethacin—Abdominal pain—Donepezil—Alzheimer's disease	0.000238	0.00116	CcSEcCtD
Indomethacin—Body temperature increased—Donepezil—Alzheimer's disease	0.000238	0.00116	CcSEcCtD
Indomethacin—Somnolence—Rivastigmine—Alzheimer's disease	0.000238	0.00116	CcSEcCtD
Indomethacin—Decreased appetite—Memantine—Alzheimer's disease	0.000238	0.00116	CcSEcCtD
Indomethacin—Fatigue—Memantine—Alzheimer's disease	0.000236	0.00115	CcSEcCtD
Indomethacin—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000236	0.00114	CcSEcCtD
Indomethacin—Constipation—Memantine—Alzheimer's disease	0.000234	0.00114	CcSEcCtD
Indomethacin—Pain—Memantine—Alzheimer's disease	0.000234	0.00114	CcSEcCtD
Indomethacin—PTGS1—central nervous system—Alzheimer's disease	0.000233	0.00322	CbGeAlD
Indomethacin—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000233	0.00113	CcSEcCtD
Indomethacin—PTGS2—nervous system—Alzheimer's disease	0.000232	0.0032	CbGeAlD
Indomethacin—Nausea—Galantamine—Alzheimer's disease	0.000231	0.00112	CcSEcCtD
Indomethacin—Fatigue—Rivastigmine—Alzheimer's disease	0.000231	0.00112	CcSEcCtD
Indomethacin—Pain—Rivastigmine—Alzheimer's disease	0.000229	0.00111	CcSEcCtD
Indomethacin—Constipation—Rivastigmine—Alzheimer's disease	0.000229	0.00111	CcSEcCtD
Indomethacin—Feeling abnormal—Memantine—Alzheimer's disease	0.000226	0.0011	CcSEcCtD
Indomethacin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000224	0.00109	CcSEcCtD
Indomethacin—PTGS2—central nervous system—Alzheimer's disease	0.000223	0.00308	CbGeAlD
Indomethacin—Hypersensitivity—Donepezil—Alzheimer's disease	0.000222	0.00108	CcSEcCtD
Indomethacin—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000221	0.00107	CcSEcCtD
Indomethacin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000219	0.00106	CcSEcCtD
Indomethacin—PTGS2—cerebellum—Alzheimer's disease	0.000218	0.00301	CbGeAlD
Indomethacin—Urticaria—Memantine—Alzheimer's disease	0.000218	0.00106	CcSEcCtD
Indomethacin—Abdominal pain—Memantine—Alzheimer's disease	0.000216	0.00105	CcSEcCtD
Indomethacin—Body temperature increased—Memantine—Alzheimer's disease	0.000216	0.00105	CcSEcCtD
Indomethacin—Asthenia—Donepezil—Alzheimer's disease	0.000216	0.00105	CcSEcCtD
Indomethacin—Pruritus—Donepezil—Alzheimer's disease	0.000213	0.00104	CcSEcCtD
Indomethacin—Urticaria—Rivastigmine—Alzheimer's disease	0.000213	0.00103	CcSEcCtD
Indomethacin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000212	0.00103	CcSEcCtD
Indomethacin—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000212	0.00103	CcSEcCtD
Indomethacin—Diarrhoea—Donepezil—Alzheimer's disease	0.000206	0.001	CcSEcCtD
Indomethacin—Hypersensitivity—Memantine—Alzheimer's disease	0.000202	0.00098	CcSEcCtD
Indomethacin—Dizziness—Donepezil—Alzheimer's disease	0.000199	0.000968	CcSEcCtD
Indomethacin—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000197	0.000958	CcSEcCtD
Indomethacin—Asthenia—Memantine—Alzheimer's disease	0.000196	0.000954	CcSEcCtD
Indomethacin—Pruritus—Memantine—Alzheimer's disease	0.000194	0.000941	CcSEcCtD
Indomethacin—Asthenia—Rivastigmine—Alzheimer's disease	0.000192	0.000933	CcSEcCtD
Indomethacin—Vomiting—Donepezil—Alzheimer's disease	0.000192	0.000931	CcSEcCtD
Indomethacin—Rash—Donepezil—Alzheimer's disease	0.00019	0.000923	CcSEcCtD
Indomethacin—Dermatitis—Donepezil—Alzheimer's disease	0.00019	0.000922	CcSEcCtD
Indomethacin—Pruritus—Rivastigmine—Alzheimer's disease	0.00019	0.00092	CcSEcCtD
Indomethacin—Headache—Donepezil—Alzheimer's disease	0.000189	0.000917	CcSEcCtD
Indomethacin—Diarrhoea—Memantine—Alzheimer's disease	0.000187	0.00091	CcSEcCtD
Indomethacin—PTGS1—brain—Alzheimer's disease	0.000185	0.00256	CbGeAlD
Indomethacin—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000183	0.00089	CcSEcCtD
Indomethacin—Dizziness—Memantine—Alzheimer's disease	0.000181	0.000879	CcSEcCtD
Indomethacin—Nausea—Donepezil—Alzheimer's disease	0.000179	0.00087	CcSEcCtD
Indomethacin—Dizziness—Rivastigmine—Alzheimer's disease	0.000177	0.00086	CcSEcCtD
Indomethacin—PTGS2—brain—Alzheimer's disease	0.000177	0.00245	CbGeAlD
Indomethacin—Vomiting—Memantine—Alzheimer's disease	0.000174	0.000845	CcSEcCtD
Indomethacin—Rash—Memantine—Alzheimer's disease	0.000173	0.000838	CcSEcCtD
Indomethacin—Dermatitis—Memantine—Alzheimer's disease	0.000173	0.000838	CcSEcCtD
Indomethacin—Headache—Memantine—Alzheimer's disease	0.000172	0.000833	CcSEcCtD
Indomethacin—Vomiting—Rivastigmine—Alzheimer's disease	0.00017	0.000827	CcSEcCtD
Indomethacin—Rash—Rivastigmine—Alzheimer's disease	0.000169	0.00082	CcSEcCtD
Indomethacin—Dermatitis—Rivastigmine—Alzheimer's disease	0.000169	0.000819	CcSEcCtD
Indomethacin—Headache—Rivastigmine—Alzheimer's disease	0.000168	0.000815	CcSEcCtD
Indomethacin—Nausea—Memantine—Alzheimer's disease	0.000163	0.00079	CcSEcCtD
Indomethacin—Nausea—Rivastigmine—Alzheimer's disease	0.000159	0.000773	CcSEcCtD
Indomethacin—ABCB1—nervous system—Alzheimer's disease	0.000143	0.00198	CbGeAlD
Indomethacin—ABCB1—central nervous system—Alzheimer's disease	0.000138	0.00191	CbGeAlD
Indomethacin—ABCB1—cerebellum—Alzheimer's disease	0.000135	0.00186	CbGeAlD
Indomethacin—ABCB1—brain—Alzheimer's disease	0.00011	0.00151	CbGeAlD
Indomethacin—SLCO1A2—Metabolism—CALM1—Alzheimer's disease	5.98e-06	3.81e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—MTHFR—Alzheimer's disease	5.97e-06	3.81e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—MTHFR—Alzheimer's disease	5.97e-06	3.81e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS2—Alzheimer's disease	5.97e-06	3.8e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PPARG—Alzheimer's disease	5.96e-06	3.8e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PPARG—Alzheimer's disease	5.96e-06	3.8e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—APOE—Alzheimer's disease	5.96e-06	3.8e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GSK3B—Alzheimer's disease	5.95e-06	3.79e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	5.94e-06	3.79e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	5.94e-06	3.78e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IGF1—Alzheimer's disease	5.93e-06	3.78e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—HMOX1—Alzheimer's disease	5.91e-06	3.77e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOTCH1—Alzheimer's disease	5.91e-06	3.77e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CAV1—Alzheimer's disease	5.9e-06	3.76e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CREB1—Alzheimer's disease	5.9e-06	3.76e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.87e-06	3.74e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—INS—Alzheimer's disease	5.87e-06	3.74e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CHAT—Alzheimer's disease	5.87e-06	3.74e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TPI1—Alzheimer's disease	5.87e-06	3.74e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—INS—Alzheimer's disease	5.85e-06	3.73e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—INS—Alzheimer's disease	5.85e-06	3.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.82e-06	3.71e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GAPDH—Alzheimer's disease	5.79e-06	3.69e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL2—Alzheimer's disease	5.77e-06	3.68e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—MTHFR—Alzheimer's disease	5.76e-06	3.67e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—A2M—Alzheimer's disease	5.73e-06	3.66e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.69e-06	3.63e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IGF1—Alzheimer's disease	5.68e-06	3.62e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PLCB1—Alzheimer's disease	5.65e-06	3.6e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MAOB—Alzheimer's disease	5.62e-06	3.58e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—AKT1—Alzheimer's disease	5.6e-06	3.57e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—A2M—Alzheimer's disease	5.6e-06	3.57e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	5.59e-06	3.57e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CALM1—Alzheimer's disease	5.58e-06	3.56e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CALM1—Alzheimer's disease	5.58e-06	3.56e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—APOE—Alzheimer's disease	5.56e-06	3.55e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—APOE—Alzheimer's disease	5.56e-06	3.55e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ACHE—Alzheimer's disease	5.56e-06	3.54e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—GSK3B—Alzheimer's disease	5.55e-06	3.54e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CASP3—Alzheimer's disease	5.54e-06	3.53e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—INS—Alzheimer's disease	5.53e-06	3.52e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CAV1—Alzheimer's disease	5.51e-06	3.51e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CAV1—Alzheimer's disease	5.51e-06	3.51e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CREB1—Alzheimer's disease	5.5e-06	3.51e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—INPP5D—Alzheimer's disease	5.49e-06	3.5e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—MTHFR—Alzheimer's disease	5.47e-06	3.49e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ABCA1—Alzheimer's disease	5.47e-06	3.49e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—INS—Alzheimer's disease	5.47e-06	3.49e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—AKT1—Alzheimer's disease	5.47e-06	3.48e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	5.41e-06	3.45e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—LPL—Alzheimer's disease	5.41e-06	3.45e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CALM1—Alzheimer's disease	5.38e-06	3.43e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NOS3—Alzheimer's disease	5.38e-06	3.43e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—APOE—Alzheimer's disease	5.36e-06	3.42e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.35e-06	3.41e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CAV1—Alzheimer's disease	5.31e-06	3.39e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.3e-06	3.38e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—A2M—Alzheimer's disease	5.23e-06	3.33e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS1—Alzheimer's disease	5.21e-06	3.32e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ENO1—Alzheimer's disease	5.21e-06	3.32e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—Alzheimer's disease	5.19e-06	3.31e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NOS3—Alzheimer's disease	5.15e-06	3.28e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—NOS3—Alzheimer's disease	5.13e-06	3.27e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—NOS3—Alzheimer's disease	5.13e-06	3.27e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—LPL—Alzheimer's disease	5.13e-06	3.27e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CALM1—Alzheimer's disease	5.11e-06	3.26e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.11e-06	3.26e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP2D6—Alzheimer's disease	5.11e-06	3.25e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOE—Alzheimer's disease	5.1e-06	3.25e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—INS—Alzheimer's disease	5.09e-06	3.25e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK8—Alzheimer's disease	5.09e-06	3.25e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CAV1—Alzheimer's disease	5.05e-06	3.22e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ACHE—Alzheimer's disease	4.99e-06	3.18e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PRKCG—Alzheimer's disease	4.98e-06	3.18e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	4.93e-06	3.14e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—Alzheimer's disease	4.91e-06	3.13e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MTHFR—Alzheimer's disease	4.87e-06	3.1e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ACHE—Alzheimer's disease	4.87e-06	3.1e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—NOS3—Alzheimer's disease	4.85e-06	3.09e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—Alzheimer's disease	4.84e-06	3.09e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—Alzheimer's disease	4.84e-06	3.09e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—BCHE—Alzheimer's disease	4.84e-06	3.09e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—INPP5D—Alzheimer's disease	4.81e-06	3.07e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	4.8e-06	3.06e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS3—Alzheimer's disease	4.8e-06	3.06e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—INS—Alzheimer's disease	4.75e-06	3.03e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—INS—Alzheimer's disease	4.75e-06	3.03e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.72e-06	3.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CCR5—Alzheimer's disease	4.72e-06	3.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	4.72e-06	3.01e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—Alzheimer's disease	4.7e-06	3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—HMOX1—Alzheimer's disease	4.69e-06	2.99e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—Alzheimer's disease	4.69e-06	2.99e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—Alzheimer's disease	4.69e-06	2.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	4.67e-06	2.98e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ENO1—Alzheimer's disease	4.67e-06	2.98e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—Alzheimer's disease	4.67e-06	2.98e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.66e-06	2.97e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—Alzheimer's disease	4.64e-06	2.96e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTHFR—Alzheimer's disease	4.62e-06	2.94e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	4.58e-06	2.92e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—INS—Alzheimer's disease	4.58e-06	2.92e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLCB1—Alzheimer's disease	4.57e-06	2.91e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ENO1—Alzheimer's disease	4.56e-06	2.91e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS1—Alzheimer's disease	4.56e-06	2.91e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CALM1—Alzheimer's disease	4.55e-06	2.9e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ACHE—Alzheimer's disease	4.55e-06	2.9e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—Alzheimer's disease	4.53e-06	2.89e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	4.5e-06	2.87e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CAV1—Alzheimer's disease	4.49e-06	2.86e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.48e-06	2.86e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	4.47e-06	2.85e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NOS3—Alzheimer's disease	4.46e-06	2.85e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—Alzheimer's disease	4.44e-06	2.83e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—Alzheimer's disease	4.43e-06	2.83e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCA1—Alzheimer's disease	4.43e-06	2.82e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—Alzheimer's disease	4.41e-06	2.81e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—Alzheimer's disease	4.39e-06	2.8e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—Alzheimer's disease	4.37e-06	2.79e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—INS—Alzheimer's disease	4.35e-06	2.78e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—BCHE—Alzheimer's disease	4.34e-06	2.77e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—Alzheimer's disease	4.34e-06	2.77e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—Alzheimer's disease	4.31e-06	2.75e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CALM1—Alzheimer's disease	4.31e-06	2.75e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—Alzheimer's disease	4.3e-06	2.74e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—LPL—Alzheimer's disease	4.29e-06	2.74e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—Alzheimer's disease	4.28e-06	2.73e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ENO1—Alzheimer's disease	4.26e-06	2.72e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	4.26e-06	2.72e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CAV1—Alzheimer's disease	4.26e-06	2.71e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—BCHE—Alzheimer's disease	4.24e-06	2.7e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	4.18e-06	2.66e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—Alzheimer's disease	4.17e-06	2.66e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NOS3—Alzheimer's disease	4.17e-06	2.66e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NOS3—Alzheimer's disease	4.17e-06	2.66e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	4.1e-06	2.61e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—Alzheimer's disease	4.08e-06	2.6e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.02e-06	2.56e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NOS3—Alzheimer's disease	4.02e-06	2.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK8—Alzheimer's disease	4.02e-06	2.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—Alzheimer's disease	4e-06	2.55e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS2—Alzheimer's disease	4e-06	2.55e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLCB1—Alzheimer's disease	4e-06	2.55e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—Alzheimer's disease	4e-06	2.55e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	3.97e-06	2.53e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOTCH1—Alzheimer's disease	3.97e-06	2.53e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—BCHE—Alzheimer's disease	3.96e-06	2.53e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—Alzheimer's disease	3.95e-06	2.52e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.88e-06	2.47e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—Alzheimer's disease	3.88e-06	2.47e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—INS—Alzheimer's disease	3.87e-06	2.47e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—Alzheimer's disease	3.87e-06	2.46e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—Alzheimer's disease	3.82e-06	2.43e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARGC1A—Alzheimer's disease	3.82e-06	2.43e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—Alzheimer's disease	3.81e-06	2.43e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—Alzheimer's disease	3.81e-06	2.43e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMOX1—Alzheimer's disease	3.8e-06	2.42e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	3.74e-06	2.38e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—GSK3B—Alzheimer's disease	3.72e-06	2.37e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—Alzheimer's disease	3.71e-06	2.36e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CREB1—Alzheimer's disease	3.69e-06	2.35e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—Alzheimer's disease	3.67e-06	2.34e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—INS—Alzheimer's disease	3.67e-06	2.34e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.67e-06	2.34e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	3.62e-06	2.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CALM1—Alzheimer's disease	3.61e-06	2.3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—Alzheimer's disease	3.6e-06	2.29e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—Alzheimer's disease	3.59e-06	2.29e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAV1—Alzheimer's disease	3.57e-06	2.27e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—Alzheimer's disease	3.56e-06	2.27e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—Alzheimer's disease	3.55e-06	2.26e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—Alzheimer's disease	3.49e-06	2.23e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—LPL—Alzheimer's disease	3.47e-06	2.21e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	3.43e-06	2.18e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	3.41e-06	2.17e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—Alzheimer's disease	3.4e-06	2.17e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—Alzheimer's disease	3.4e-06	2.17e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	3.34e-06	2.13e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMOX1—Alzheimer's disease	3.33e-06	2.12e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—Alzheimer's disease	3.25e-06	2.07e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—Alzheimer's disease	3.22e-06	2.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—Alzheimer's disease	3.17e-06	2.02e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—Alzheimer's disease	3.13e-06	2e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—Alzheimer's disease	3.13e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	3.12e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.12e-06	1.99e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—Alzheimer's disease	3.11e-06	1.98e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	3.11e-06	1.98e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—Alzheimer's disease	3.11e-06	1.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—INS—Alzheimer's disease	3.07e-06	1.96e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LPL—Alzheimer's disease	3.04e-06	1.94e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—Alzheimer's disease	3e-06	1.91e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—Alzheimer's disease	2.93e-06	1.87e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CALM1—Alzheimer's disease	2.92e-06	1.86e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—Alzheimer's disease	2.91e-06	1.86e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAV1—Alzheimer's disease	2.88e-06	1.84e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—Alzheimer's disease	2.87e-06	1.83e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.84e-06	1.81e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.81e-06	1.79e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—Alzheimer's disease	2.8e-06	1.79e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.74e-06	1.75e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—Alzheimer's disease	2.7e-06	1.72e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.62e-06	1.67e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.61e-06	1.67e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.59e-06	1.65e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—Alzheimer's disease	2.56e-06	1.63e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.56e-06	1.63e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.56e-06	1.63e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—Alzheimer's disease	2.55e-06	1.63e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—Alzheimer's disease	2.54e-06	1.62e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.53e-06	1.61e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—INS—Alzheimer's disease	2.49e-06	1.59e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—Alzheimer's disease	2.47e-06	1.58e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.39e-06	1.52e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—Alzheimer's disease	2.39e-06	1.52e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.38e-06	1.52e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—Alzheimer's disease	2.37e-06	1.51e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.36e-06	1.51e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—Alzheimer's disease	2.36e-06	1.5e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—Alzheimer's disease	2.36e-06	1.5e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.28e-06	1.45e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—INS—Alzheimer's disease	2.23e-06	1.42e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—Alzheimer's disease	2.23e-06	1.42e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.22e-06	1.42e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—Alzheimer's disease	2.21e-06	1.41e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—Alzheimer's disease	2.18e-06	1.39e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—INS—Alzheimer's disease	2.18e-06	1.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—Alzheimer's disease	2.13e-06	1.36e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.08e-06	1.32e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—Alzheimer's disease	2.05e-06	1.31e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—INS—Alzheimer's disease	2.04e-06	1.3e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—Alzheimer's disease	2e-06	1.27e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.96e-06	1.25e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—Alzheimer's disease	1.92e-06	1.22e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—Alzheimer's disease	1.92e-06	1.22e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.91e-06	1.22e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—Alzheimer's disease	1.85e-06	1.18e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.79e-06	1.14e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.79e-06	1.14e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—Alzheimer's disease	1.76e-06	1.12e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.75e-06	1.11e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.63e-06	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—Alzheimer's disease	1.6e-06	1.02e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—Alzheimer's disease	1.56e-06	9.95e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—Alzheimer's disease	1.48e-06	9.43e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—Alzheimer's disease	1.24e-06	7.9e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—Alzheimer's disease	1e-06	6.39e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—Alzheimer's disease	9e-07	5.74e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—Alzheimer's disease	8.79e-07	5.6e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—Alzheimer's disease	8.21e-07	5.23e-06	CbGpPWpGaD
